Letters by company

Samsung Biologics Co Ltd

1 letter discussing 207940. Everything written about it on this site is on its ticker page.

Seafarer Capital Partners Portfolio Review The Seafarer Overseas Growth and Income Fund credited Samsung Electronics, Samsung SDI, Accton Technology and Delta Electronics with technology-led gains, while UPL, L&T Technology Services and Hermès detracted amid the Middle East conflict. The fund added ASMPT, HD Hyundai Marine Solution and NARI Technology, and exited Samsung Epis Holdings and Samsung C&T. first quarter of 2026 006400 $33B443060 $5.6BHRMS